These effects are particularly remarkable because MA9 causes very aggressive AML in mice that nevertheless expressed Calcrl only at moderate levels, and because olcegepant has a ~200-fold lower affinity for the murine versus the human CGRP receptor [1]. This evidence concerns the gene CALCRL and acute myeloid leukemia.